Works by SONNENBLICK, AMIR


Results: 41
    1
    2
    3

    Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.

    Published in:
    2021
    By:
    • Bines, José;
    • Clark, Emma;
    • Barton, Claire;
    • Restuccia, Eleonora;
    • Procter, Marion;
    • Sonnenblick, Amir;
    • Fumagalli, Debora;
    • Parlier, Damien;
    • Arahmani, Amal;
    • Baselga, José;
    • Viale, Giuseppe;
    • Reaby, Linda L.;
    • Frank, Elizabeth;
    • Gelber, Richard D.;
    • Piccart, Martine;
    • Jackisch, Christian;
    • Petersen, Jennifer A.
    Publication type:
    journal article
    4
    5

    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00549-8
    By:
    • Rotem, Ofer;
    • Peretz, Idit;
    • Leviov, Michelle;
    • Kuchuk, Iryna;
    • Itay, Amit;
    • Tokar, Margarita;
    • Paluch-Shimon, Shani;
    • Maimon, Ofra;
    • Yerushalmi, Rinat;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Goldvaser, Hadar;
    • Samih, Yosef;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    6

    Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

    Published in:
    NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00277-x
    By:
    • Zahavi, Tamar;
    • Salmon-Divon, Mali;
    • Salgado, Roberto;
    • Elkin, Michael;
    • Hermano, Esther;
    • Rubinstein, Ariel M.;
    • Francis, Prudence A.;
    • Di Leo, Angelo;
    • Viale, Giuseppe;
    • de Azambuja, Evandro;
    • Ameye, Lieveke;
    • Sotiriou, Christos;
    • Salmon, Asher;
    • Kravchenko-Balasha, Nataly;
    • Sonnenblick, Amir
    Publication type:
    Article
    7

    p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.

    Published in:
    International Journal of Oncology, 2018, v. 52, n. 2, p. 424, doi. 10.3892/ijo.2017.4212
    By:
    • Sonnenblick, Amir;
    • Salgado, Roberto;
    • Brohée, Sylvain;
    • Zahavi, Tamar;
    • Peretz, Tamar;
    • Van Den Eynden, Gert;
    • Rouas, Ghizlane;
    • Salmon, Asher;
    • Francis, Prudence A.;
    • Di Leo, Angelo;
    • Crown, John P.A.;
    • Viale, Giuseppe;
    • Daly, Laura;
    • Javdan, Bahar;
    • Fujisawa, Sho;
    • De Azambuja, Evandro;
    • Lieveke, Ameye;
    • Piccart, Martine J.;
    • Bromberg, Jacqueline F.;
    • Sotiriou, Christos
    Publication type:
    Article
    8
    9
    10

    Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.

    Published in:
    Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-023-01921-9
    By:
    • Alkhatib, Heba;
    • Conage-Pough, Jason;
    • Roy Chowdhury, Sangita;
    • Shian, Denen;
    • Zaid, Deema;
    • Rubinstein, Ariel M.;
    • Sonnenblick, Amir;
    • Peretz-Yablonsky, Tamar;
    • Granit, Avital;
    • Carmon, Einat;
    • Kohale, Ishwar N.;
    • Boughey, Judy C.;
    • Goetz, Matthew P.;
    • Wang, Liewei;
    • White, Forest M.;
    • Kravchenko-Balasha, Nataly
    Publication type:
    Article
    11
    12

    Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

    Published in:
    2016
    By:
    • Sonnenblick, Amir;
    • de Azambuja, Evandro;
    • Agbor-tarh, Dominique;
    • Bradbury, Ian;
    • Campbell, Christine;
    • Yingjie Huang;
    • Dueck, Amylou C.;
    • Pritchard, Kathleen I.;
    • Wolff, Antonio C.;
    • Jackisch, Christian;
    • Lang, Istvan;
    • Untch, Michael;
    • Smith, Ian;
    • Boyle, Frances;
    • Binghe Xu;
    • Gomez, Henry;
    • Perez, Edith A.;
    • Piccart, Martine;
    • Azim Jr., Hatem A.;
    • Huang, Yingjie
    Publication type:
    journal article
    13
    14
    15
    16
    17

    Reactive stroma and trastuzumab resistance in HER2‐positive early breast cancer.

    Published in:
    International Journal of Cancer, 2020, v. 147, n. 1, p. 266, doi. 10.1002/ijc.32859
    By:
    • Sonnenblick, Amir;
    • Salmon‐Divon, Mali;
    • Salgado, Roberto;
    • Dvash, Efrat;
    • Pondé, Noam;
    • Zahavi, Tamar;
    • Salmon, Asher;
    • Loibl, Sibylle;
    • Denkert, Carsten;
    • Joensuu, Heikki;
    • Ameye, Lieveke;
    • Van den Eynden, Gert;
    • Kellokumpu‐Lehtinen, Pirkko‐Liisa;
    • Azaria, Amos;
    • Loi, Sherene;
    • Michiels, Stefan;
    • Richard, François;
    • Sotiriou, Christos
    Publication type:
    Article
    18
    19
    20
    21
    22

    ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 210, n. 1, p. 167, doi. 10.1007/s10549-024-07549-7
    By:
    • Goldvaser, Hadar;
    • Yerushalmi, Rinat;
    • Mutai, Raz;
    • Kuchuk, Iryna;
    • Toker, Margarita;
    • Paluch-Shimon, Shani;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Sela, Gil Bar-;
    • Shai, Ayelet;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    23

    ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 3, p. 167, doi. 10.1007/s10549-024-07549-7
    By:
    • Goldvaser, Hadar;
    • Yerushalmi, Rinat;
    • Mutai, Raz;
    • Kuchuk, Iryna;
    • Toker, Margarita;
    • Paluch-Shimon, Shani;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Sela, Gil Bar-;
    • Shai, Ayelet;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    24
    25

    Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00586-3
    By:
    • Shachar, Shlomit S.;
    • Leviov, Michelle;
    • Yerushalmi, Rinat;
    • Drumea, Karen;
    • Tokar, Margarita;
    • Soussan-Gutman, Lior;
    • Bareket-Samish, Avital;
    • Sonnenblick, Amir;
    • Ben-Baruch, Noa;
    • Evron, Ella;
    • Gal-Yam, Einav Nili;
    • Paluch-Shimon, Shani;
    • Bar-Sela, Gil;
    • Goldvaser, Hadar;
    • Stemmer, Salomon M.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Potential Refinement of Recurrence Score by pSTAT3 Status.

    Published in:
    Genes, 2022, v. 13, n. 3, p. 438, doi. 10.3390/genes13030438
    By:
    • Grinshpun, Albert;
    • Cohen, Yogev;
    • Zick, Aviad;
    • Kadouri, Luna;
    • Hamburger, Tamar;
    • Nisman, Benjamin;
    • Allweis, Tanir M.;
    • Oprea, Gabriela;
    • Peretz, Tamar;
    • Uziely, Beatrice;
    • Sonnenblick, Amir
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2‐negative breast cancer patients in Israel: A registry analysis.

    Published in:
    Breast Journal, 2020, v. 26, n. 10, p. 2096, doi. 10.1111/tbj.13870
    By:
    • Bar-Sela, Gil;
    • Samih, Yousef;
    • Yerushalmi, Rinat;
    • Leviov, Michelle;
    • Efrat Ben‐Baruch, Noa;
    • Kuchuk, Iryna;
    • Tokar, Margarita;
    • Peretz‐Yablonski, Tamar;
    • Sonnenblick, Amir;
    • Soussan‐Gutman, Lior;
    • Bareket‐Samish, Avital;
    • Fried, Georgeta;
    • Paluch‐Shimon, Shani;
    • Kaufman, Bella;
    • Hammerman, Ariel;
    • Liebermann, Nicky;
    • Stemmer, Salomon M.
    Publication type:
    Article
    39
    41

    Constitutive phosphorylated STAT3-associated gene signature is predictive for trastuzumab resistance in primary HER2-positive breast cancer.

    Published in:
    BMC Medicine, 2015, v. 13, n. 1, p. 177, doi. 10.1186/s12916-015-0416-2
    By:
    • Sonnenblick, Amir;
    • Brohée, Sylvain;
    • Fumagalli, Debora;
    • Vincent, Delphine;
    • Venet, David;
    • Ignatiadis, Michail;
    • Salgado, Roberto;
    • Van den Eynden, Gert;
    • Rothé, Françoise;
    • Desmedt, Christine;
    • Neven, Patrick;
    • Loibl, Sibylle;
    • Denkert, Carsten;
    • Joensuu, Heikki;
    • Loi, Sherene;
    • Sirtaine, Nicolas;
    • Kellokumpu-Lehtinen, Pirkko-Liisa;
    • Piccart, Martine;
    • Sotiriou, Christos
    Publication type:
    Article